Organization

Oncology Consultants PA

2 abstracts

Abstract
MT-6402, an engineered toxin body (ETB) targeting PD-L1: Interim efficacy and safety data.
Org: Mary Crowley Cancer Research Center, Washington University in Saint Louis, Brown Cancer Center, Sanford Cancer Center, Prisma Health Cancer Institute,
Abstract
Is physician-patient language discordance a barrier for clinical trial enrollment in patients with cancer? A real-life study.
Org: University of Texas Health and Science at San Antonio, Oncology Consultants, Division of Hematology-Oncology, Department of Medicine, Seoul Medical Center, Seo-Gu, South Korea, Facultad de Medicina del Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico, UT Health San Antonio Cancer Center,